Close

Amylin Pharma (AMLN) Names Christian Weyer, MD, to SVP of R&D, Orville Kolterman, MD, to CMO and SVP

June 1, 2010 8:16 AM EDT Send to a Friend
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that Christian Weyer, MD has been appointed Senior Vice President, Research and Development ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login